Winslow Evans & Crocker’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$113K Hold
2,000
0.02% 416
2020
Q3
$97K Hold
2,000
0.02% 363
2020
Q2
$111K Hold
2,000
0.03% 342
2020
Q1
$102K Hold
2,000
0.03% 328
2019
Q4
$156K Hold
2,000
0.04% 326
2019
Q3
$128K Hold
2,000
0.04% 350
2019
Q2
$118K Sell
2,000
-24
-1% -$1.42K 0.03% 366
2019
Q1
$116K Buy
2,024
+24
+1% +$1.28K 0.03% 359
2018
Q4
$100K Hold
2,000
0.03% 355
2018
Q3
$142K Hold
2,000
0.04% 319
2018
Q2
$106K Hold
2,000
0.03% 361
2018
Q1
$104K Hold
2,000
0.03% 350
2017
Q4
$117K Hold
2,000
0.04% 335
2017
Q3
$111K Hold
2,000
0.04% 344
2017
Q2
$154K Hold
2,000
0.04% 353
2017
Q1
$149K Hold
2,000
0.05% 343
2016
Q4
$135K Sell
2,000
-4,100
-67% -$264K 0.04% 349
2016
Q3
$407K Buy
6,100
+4,100
+205% +$261K 0.12% 184
2016
Q2
$119K Hold
2,000
0.04% 349
2016
Q1
$97.3K Hold
2,000
0.03% 373
2015
Q4
$108K Hold
2,000
0.03% 380
2015
Q3
$96.4K Hold
2,000
0.03% 395
2015
Q2
$94.8K Hold
2,000
0.03% 433
2015
Q1
$92K Hold
2,000
0.03% 438
2014
Q4
$94.3K Hold
2,000
0.03% 426
2014
Q3
$69.7K Hold
2,000
0.02% 497
2014
Q2
$71.1K Hold
2,000
0.02% 436
2014
Q1
$76.8K Hold
2,000
0.03% 420
2013
Q4
$65K Buy
+2,000
New +$60.1K 0.02% 471

Other funds holding NUVA

Winslow Evans & Crocker's NUVA Position: Q4 2020 in Review

Winslow Evans & Crocker held its NuVasive, Inc. (NUVA) position steady in Q4 2020 at 2,000 shares worth $113K. The position accounts for 0.02% of the portfolio, ranked #416.

Winslow Evans & Crocker first reported a position in NUVA in Q4 2013 and has held it in 29 quarters since. The position peaked at $407K in Q3 2016. 280 funds tracked by Wall St. Rank hold NUVA as of Q4 2020.

  • Winslow Evans & Crocker held 2,000 shares of NuVasive, Inc. worth $113K as of Q4 2020.
  • Winslow Evans & Crocker left its NuVasive, Inc. share count unchanged in Q4 2020.
  • NuVasive, Inc. made up 0.02% of Winslow Evans & Crocker's portfolio in Q4 2020, its #416 holding.
  • Winslow Evans & Crocker first reported a position in NuVasive, Inc. in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's NuVasive, Inc. position peaked at $407K in Q3 2016.
  • 280 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.